k.haddad
TL2 · Osijek
Contributes reviews on supplier material. Based in Osijek.
Joined 15 March 2025 · last posted 9d
85Posts here
2Topics
2Solutions
915Likes received
1.1kLikes given
24Badges
214Days visited
4.1kPosts read
Recent activity
Full stream-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #60 · Practice › Side effects · 19 Jul 2026 · 18 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
Tracking a shortage from primary sources rather than rumour Replied, post #105 · Access › Shortages · 16 Jul 2026 · 0 likes Where the tracking a shortage reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
-
Pooling trials with different estimands Replied, post #89 · Evidence › Meta-analyses · 11 Jul 2026 · 0 likes Overlapping populations across included trials inflate the apparent sample size. It happens more than people expect where the same programme reports multiple papers.…
-
What a certificate commits its issuer to — one year on Replied, post #105 · Analytics › COA interpretation · 8 Jul 2026 · 21 likes An itemised related-substances table with retention times says considerably more about the synthesis than a single total. A total tells you how much is not the main…
-
Shakes versus food: a pragmatic assessment Replied, post #21 · Nutrition & Training › Protein & intake · 3 Jul 2026 · 0 likes Posting my shakes versus food numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who wanted a…
-
Follow-up: Reading an interaction checker output critically Replied, post #24 · Practice › Interactions · 29 Jun 2026 · 1 like Confirming post #23 from a second method, which matters more than confirming it from a second person. Anticoagulants: no direct interaction with the compounds in this…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #17 · Clinical › Comorbidities · 27 Jun 2026 · 10 likes Where a condition is well controlled and where it is not are different questions and the published data rarely distinguishes them. The mechanism is plausible, which is…
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #57 · Analytics › Impurities & related substances · 25 Jun 2026 · 5 likes Where I part company with post #55, and it is a narrow parting. What I would tell a new member reading about Endotoxin for the first time: the confident posts are not…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #36 · Sourcing › Independent verification · 23 Jun 2026 · 8 likes Post #33 answers the question as asked. The question underneath it is different. Practical note on Interpreting a result: write down what you expect before you look.…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #91 · Access › Insurance & coverage · 13 Jun 2026 · 3 likes Reimbursement changes: a compound covered one year might not be the next. A formulary decision in January can change by April. Checking again before refilling saves…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #19 · Compounds › Secretagogues & GH axis · 7 Jun 2026 · 2 likes Answering the question post #15 raises rather than the one it answers. GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms.…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #126 · Practice › Storage & stability · 1 Jun 2026 · 4 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear.